WebThe generic name usually includes the active ingredient(s) of the product. Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate ... The NDC Packaged Code 61958-1101-1 is assigned to a package of 30 tablet, film coated in 1 bottle of Complera, a human prescription drug labeled by Gilead Sciences, Inc.. The product's … Websuicidal thoughts. depression. liver problems. chronic kidney disease stage 4 (severe) chronic kidney disease stage 5 (failure) osteomalacia, or softening of bones. low amount of phosphate in the ...
emtricitabine, rilpivirine, and tenofovir (Complera, Odefsey)
WebAnnual Drug Patent Expirations for COMPLERA. Complera is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug and one Paragraph IV challenge. Drug patent litigation for COMPLERA. This drug has three hundred and five patent family members in fifty ... WebApr 1, 2012 · Complera (Rilpivirine/Tenofovir Disoproxil Fumarate/FTC) Complera Positively Aware March 31, 2012 Brand name: Complera Generic name: rilpivirine/emtricitabine/tenofovir, or RPV/FTC/TDF... going to school while on disability
Drugs and Therapeutics (D & T) Committee Meeting Results for: …
Web9 rows · Nov 9, 2024 · DESCRIPTION. COMPLERA is a fixed-dose combination tablet containing emtricitabine, rilpivirine ... WebDec 14, 2011 · Drugs and Therapeutics (D & T) Committee Meeting Results for: December 14, 2011. Drug Name. Review Type. Committee Recommendation. Prior Approval Status Final Determination. Complera. New Drug Initial Review. Require Prior Approval. WebAug 17, 2024 · The most common side effects of rilpivirine, one of the medicines in Complera, include: depression. trouble sleeping. headache. The most common side … going to school with sims mod